Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: A prevalent cohort study

International Urology and Nephrology

Volumn 43, Issue 1, 2011, Pages 215-224

  Remport, Adam ^a   Keszei, Andras ^b,c   Vamos, Eszter Panna ^b,d   Novak, Marta ^b,e   Jaray, Jeno ^b   Rosivall, Laszlo ^b   Mucsi, Istvan ^b   Molnar, Miklos Zsolt ^b  

^a Szent Imre Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Chronic renal disease; Dialysis duration; Kidney transplantation; Mortality; Transplantation outcomes

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DIALYSIS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PREVALENCE; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; HUNGARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953807818     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9700-4     Document Type: Article

References (39)

1. (1998) Renal transplantation: access and outcomes. United States Renal Data System. Am J Kidney Dis 32:S89-S97
2. Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985-992
3. Lindholm A, Albrechtsen D, Frodin L et al (1995) Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60:451-457
4. Banerjee D, Contreras G, Jaraba I et al (2009) Chronic kidney disease stages 3-5 and cardiovascular disease in the veterans affairs population. Int Urol Nephrol 41:443-451
5. Roake JA, Cahill AP, Gray CM et al (1996) Preemptive cadaveric renal transplantation - clinical outcome. Transplantation 62:1411-1416 (Pubitemid 26404661)
6. Mange KC, Joffe MM, Feldman HI (2001) Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 344:726-731 (Pubitemid 32204990)
7. Meier-Kriesche HU, Port FK, Ojo AO et al (2000) Effect of waiting time on renal transplant outcome. Kidney Int 58:1311-1317
8. DeLoach SS, Berns JS (2007) Arterial stiffness and vascular calcification in dialysis patients: new measures of cardiovascular risk. Semin Dial 20:477-479
9. Yoshino M, Kuhlmann MK, Kotanko P et al (2006) International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17:3510-3519 (Pubitemid 44865294)
10. Cosio FG, Alamir A, Yim S et al (1998) Patient survival after renal transplantation: I. The impact of dialysis pretransplant. Kidney Int 53:767-772
11. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J et al (2005) Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 20:167-175 (Pubitemid 40207623)
12. El-Agroudy AE, Bakr MA, Shehab El-Dein AB et al (2003) Death with functioning graft in living donor kidney transplantation: analysis of risk factors. Am J Nephrol 23:186-193 (Pubitemid 36649335)
13. Resende L, Guerra J, Santana A et al (2009) Influence of dialysis duration and modality on kidney transplant outcomes. Transplant Proc 41:837-839
14. Meier-Kriesche HU, Kaplan B (2002) Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 74:1377-1381
15. Yarlagadda SG, Coca SG, Garg AX et al. (2008) Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 23(9):2995-3003
16. Levey A, Greene T, Kusek J et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine {Abstract}. J Am Soc Nephrol 11:155A
17. Craven J, Littlefield C, Rodin G et al (1991) The endstage renal disease severity index (ESRD-SI). Psychol Med 21:237-243
18. Molnar MZ, Novak M, Ambrus C et al (2005) Anemia in kidney transplanted patients. Clin Transpl 19:825-833 (Pubitemid 41748739)
19. Molnar MZ, Novak M, Ambrus C et al (2005) Restless legs syndrome in patients after renal transplantation. Am J Kidney Dis 45:388-396 (Pubitemid 40431066)
20. Mucsi I, Molnar MZ, Ambrus C et al (2005) Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol Dial Transplant 20:571-577 (Pubitemid 40378427)
21. Molnar MZ, Szentkiralyi A, Lindner A et al (2007) Restless legs syndrome and mortality in kidney transplant recipients. Am J Kidney Dis 50:813-820 (Pubitemid 47588557)
22. Molnar MZ, Czira M, Ambrus C et al (2007) Anemia is associated with mortality in kidney-transplanted patients - a prospective cohort study. Am J Transplant 7:818-824 (Pubitemid 46481205)
23. Gill JS, Abichandani R, Kausz AT et al (2002) Mortality after kidney transplant failure: the impact of non-immunologic factors. Kidney Int 62:1875-1883 (Pubitemid 35286299)
24. Aker S, Ivens K, Grabensee B et al (1998) Cardiovascular risk factors and diseases after renal transplantation. Int Urol Nephrol 30:777-788 (Pubitemid 29125544)
25. Ponticelli C, Villa M (2002) Role of anaemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant 17(Suppl 1):41-46 (Pubitemid 34157118)
26. Gelev S, Spasovski G, Dzikova S et al (2008) Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical practice? Int Urol Nephrol 40:763-770
27. Hernandez D, Rufino M, Bartolomei S et al (2005) Clinical impact of preexisting vascular calcifications on mortality after renal transplantation. Kidney Int 67:2015-2020 (Pubitemid 40577740)
28. Rigatto C, Foley R, Jeffery J et al (2003) Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 14:462-468 (Pubitemid 36150871)
29. Rigatto C, Parfrey P, Foley R et al (2002) Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13:1084-1090 (Pubitemid 34274107)
30. Armada E, Perez C, Otero A et al (2003) Neither folic nor folinic acid normalize homocysteine levels in hemodialysis patients. Clin Nephrol 60:168-175 (Pubitemid 37121779)
31. Degenhardt TP, Grass L, Reddy S et al (1997) Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl) lysine is increased in uremia. Kidney Int 52:1064-1067
32. Mafra D, Farage NE, Azevedo DL et al (2007) Impact of serum albumin and body-mass index on survival in hemodialysis patients. Int Urol Nephrol 39:619-624 (Pubitemid 47054875)
33. Kalantar-Zadeh K, Kopple JD, Block G et al (2001) A malnutrition- inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251-1263 (Pubitemid 34193111)
34. Ammirati AL, Dalboni MA, Cendoroglo M et al (2007) The progression and impact of vascular calcification in peritoneal dialysis patients. Perit Dial Int 27:340-346 (Pubitemid 47054616)
35. Cacciarelli TV, Sumrani N, DiBenedetto A et al (1993) Influence of length of time on dialysis before transplantation on long-term renal allograft outcome. Transplant Proc 25:2474-2476 (Pubitemid 23239507)
36. Descamps-Latscha B, Herbelin A, Nguyen AT et al (1995) Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892
37. Barotfi S, Molnar M, Almasi C et al (2006) Validation of the kidney disease quality of life-short form questionnaire in kidney transplant patients. J Psychosom Res 60:495-504
38. Meier-Kriesche HU, Li S, Gruessner RW et al (2006) Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 6:1111-1131
39. Chang SH, Russ GR, Chadban SJ et al (2007) Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation 84:611-618 (Pubitemid 47429042)